Invention Grant
- Patent Title: Composition for diagnosing or predicting risk of metabolic syndrome or metabolic syndrome-related diseases using human oral microbiome
-
Application No.: US16316662Application Date: 2017-07-20
-
Publication No.: US11365452B2Publication Date: 2022-06-21
- Inventor: GwangPyo Ko , Jiyeon Si , Cheonghoon Lee
- Applicant: KoBioLabs, Inc. , Seoul National University R&DB Foundation
- Applicant Address: KR Seoul; KR Seoul
- Assignee: KoBioLabs, Inc.,Seoul National University R&DB Foundation
- Current Assignee: KoBioLabs, Inc.,Seoul National University R&DB Foundation
- Current Assignee Address: KR Seoul; KR Seoul
- Agency: Lex IP Meister, PLLC
- Priority: KR10-2016-0094299 20160725
- International Application: PCT/KR2017/007841 WO 20170720
- International Announcement: WO2018/021761 WO 20180201
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C12Q1/689 ; C12Q1/02 ; G01N33/569
Abstract:
The present invention relates to markers being capable of predicting or diagnosing the risk of metabolic syndrome or metabolic syndrome-related diseases and their use. More particularly, the present invention relates to a composition, a kit and a method for predicting or diagnosing the risk of metabolic syndrome or metabolic syndrome-related diseases by detecting Neisseria spp., Granulicatella spp., and/or Peptococcus spp. in a test sample.
Public/Granted literature
Information query
